LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: Portland Press
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: nervous system diseases
A wide variety of different functions and an impressive array of interactors have been associated with leucine-rich repeat kinase 2 (LRRK2) over the years. Here, I discuss the hypothesis that LRRK2 may be capable of interacting with different proteins at different times and places, therefore, controlling a plethora of diverse functions based on the different complexes formed. Among these, I will then focus on macroautophagy in the general context of the endolysosomal system. First, the relevance of autophagy in Parkinson's disease will be evaluated giving a brief overview of all the relevant Parkinson's disease genes; then, the association of LRRK2 with macroautophagy and the endolysosomal pathway will be analyzed based on the supporting literature.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1 Corti, O., Lesage, S. and Brice, A. (2011) What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol. Rev. 91, 1161-1218 doi:10.1152/physrev.00022.2010
    • 2 Hernandez, D.G., Reed, X. and Singleton, A.B. (2016) Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J. Neurochem. 139, 59-74 doi:10.1111/jnc.13593
    • 3 Agalliu, I., San Luciano, M., Mirelman, A., Giladi, N., Waro, B., Aasly, J. et al. (2015) Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. JAMA Neurol. 72, 58-65 doi:10.1001/jamaneurol.2014.1973
    • 4 Wang, D., Xu, L., Lv, L., Su, L.-Y., Fan, Y., Zhang, D.-F. et al. (2015) Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China. Genes Immun. 16, 112-119 doi:10.1038/gene.2014.72
    • 5 Liu, Z. and Lenardo, M.J. (2012) The role of LRRK2 in inflammatory bowel disease. Cell Res. 22, 1092-1094 doi:10.1038/cr.2012.42
    • 6 Moehle, M.S., Webber, P.J., Tse, T., Sukar, N., Standaert, D.G., DeSilva, T.M. et al. (2012) LRRK2 inhibition attenuates microglial inflammatory responses. J. Neurosci. 32, 1602-1611.2012
    • 7 Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S. et al. (2004) Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44, 601-607 doi:10.1016/j.neuron.2004.11.005
    • 8 Paisán-Ruíz, C., Jain, S., Evans, E.W., Gilks, W.P., Simón, J., van der Brug, M. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600 doi:10.1016/j.neuron.2004.10.023
    • 9 Wallings, R., Manzoni, C. and Bandopadhyay, R. (2015) Cellular processes associated with LRRK2 function and dysfunction. FEBS J. 282, 2806-2826 doi:10.1111/febs.13305
    • 10 Manzoni, C., Denny, P., Lovering, R.C. and Lewis, P.A. (2015) Computational analysis of the LRRK2 interactome. PeerJ 3, e778 doi:10.7717/peerj.778
    • 11 Han, J.-D., Bertin, N., Hao, T., Goldberg, D.S., Berriz, G.F., Zhang, L.V. et al. (2004) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430, 88-93 doi:10.1038/nature02555
    • 12 Lewis, P.A. and Manzoni, C. (2012) LRRK2 and human disease: a complicated question or a question of complexes? Sci. Signal. 5, pe2 doi: 10.1126/scisignal.2002680
    • 13 Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A. et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047 doi:10.1126/science.276.5321.2045
    • 14 Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J. et al. (2003) α-Synuclein locus triplication causes Parkinson's disease. Science 302, 841 doi:10.1126/science.1090278
  • No similar publications.

Share - Bookmark

Cite this article